Cytochrome P450 loss-of-function polymorphism genotyping on the Agilent Bioanalyzer and clinical application
出版年份 2009 全文链接
标题
Cytochrome P450 loss-of-function polymorphism genotyping on the Agilent Bioanalyzer and clinical application
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 10, Issue 12, Pages 1987-1994
出版商
Future Medicine Ltd
发表日期
2009-12-03
DOI
10.2217/pgs.09.127
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen users
- (2009) Monique J. Bijl et al. BREAST CANCER RESEARCH AND TREATMENT
- Relative Impact of Genotype and Enzyme Induction on the Metabolic Capacity of CYP2C9 in Healthy Volunteers
- (2009) SV Vormfelde et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia
- (2009) Tatsuhiko Yagihashi et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Cytochrome P450 2C19 polymorphism and clopidogrel after MI
- (2009) Sanjeev Bhattacharyya et al. LANCET
- CYP2D6 Genotype Predicts Antipsychotic Side Effects in Schizophrenia Inpatients: A Retrospective Matched Case-Control Study
- (2009) Camilla J. Kobylecki et al. NEUROPSYCHOBIOLOGY
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations
- (2009) Sarah J. Billups et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
- (2009) Johanna Sistonen et al. Pharmacogenetics and Genomics
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment
- (2008) Y. Xu et al. ANNALS OF ONCOLOGY
- Genetic Variation in the CYP2D6 Gene Is Associated With a Lower Heart Rate and Blood Pressure in β-Blocker Users
- (2008) MJ Bijl et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities
- (2008) José de Leon et al. CLINICS IN LABORATORY MEDICINE
- Pharmacogenomics and Personalized Use of Drugs
- (2008) Jing-Fang Wang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The clinical impact of pharmacogenetics on the treatment of epilepsy
- (2008) Wolfgang Löscher et al. EPILEPSIA
- Effect of CYP2C19 Genetic Polymorphisms on the Efficacy of Proton Pump Inhibitor-Based Triple Therapy forHelicobacter pyloriEradication: A Meta-Analysis
- (2008) Fujun Zhao et al. HELICOBACTER
- CYP2C19Genotype Is a Major Factor Contributing to the Highly Variable Pharmacokinetics of Voriconazole
- (2008) Johanna Weiss et al. JOURNAL OF CLINICAL PHARMACOLOGY
- CYP2C19 genotypes andHelicobacter pylorieradication
- (2008) Bor-Shyang Sheu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction
- (2008) M C Rebsamen et al. PHARMACOGENOMICS JOURNAL
- Role ofCYP2C9 andCYP2C19 polymorphisms in patients with atherosclerosis
- (2007) B. Ercan et al. CELL BIOCHEMISTRY AND FUNCTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search